|
Daunorubicin Liposomal Injection
|
|
DaunoXome
|
Daunorubicin Liposomal Injection Clinical Trials
- Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00004207 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00427414 - Not yet recruiting
Sarcoma
- Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00111345 - Recruiting
Myeloid Leukemia
- Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
ClinicalTrials.gov Identifier: NCT00355888 - Recruiting
Cancer
- Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
ClinicalTrials.gov Identifier: NCT00389428 - Recruiting
Hematologic Neoplasms
- High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
ClinicalTrials.gov Identifier: NCT00474006 - Recruiting
Acute Myelogenous Leukemia
- Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
ClinicalTrials.gov Identifier: NCT00005942 - Completed
Previously Treated Myelodysplastic Syndrome; recurrent adult acute myeloid leukemia; refractory anemia with excess blasts in transformation; ...
- Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00023777 - Active, not recruiting
Myeloid Leukemia
- Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
ClinicalTrials.gov Identifier: NCT00003315 - Active, not recruiting
Infection
- Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00002704 - Active, not recruiting
B-cell childhood acute lymphocytic leukemia; TdT positive childhood acute lymphocytic leukemia; recurrent childhood acute lymphocytic leukemia; ...
- Study of Zosuquidar, Daunorubicin, and Cytarabine in Patients Ages 55-75 with Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00129168 - Recruiting
Leukemia, Myeloid
- Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00085124 - Active, not recruiting
adult acute myeloid leukemia; secondary acute myeloid leukemia
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms
- The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (Study P04445)
ClinicalTrials.gov Identifier: NCT00266799 - Recruiting
Breast Cancer
- Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00066794 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Pharmacology Study of Aerosolized Liposomal
ClinicalTrials.gov Identifier: NCT00250120 - Active, not recruiting
Lung Diseases; Cancer
- Phase II Clinical Study of a Liposomal-Cisplatin Analogue (L-NDDP) Administered Intrapleurally in Patients with Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00004033 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
- Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
ClinicalTrials.gov Identifier: NCT00003938 - Active, not recruiting
Kidney Disease; Breast Cancer; Endocrine Cancer; Gastrointestinal Cancer; Hematopoietic and Lymphoid Cancer; Central Nervous System Cancer
- Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
ClinicalTrials.gov Identifier: NCT00046930 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia
- Cytarabine and Daunorubicin with Or Without Gemtuzumab Ozogamicin in Treating Older Patients with Acute Myeloid Leukemia Or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00121303 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00004083 - Active, not recruiting
stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
- Safety, Efficacy and Pharmacokinetics Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
ClinicalTrials.gov Identifier: NCT00148148 - Recruiting
"Hematopoietic Stem Cell Transplantation"
- PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004217 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
ClinicalTrials.gov Identifier: NCT00008359 - Active, not recruiting
Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; Eye Cancer; kidney tumor
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
- Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003934 - Active, not recruiting
untreated adult acute myeloid leukemia; untreated childhood acute myeloid leukemia and other myeloid malignancies; ...
- PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093600 - Active, not recruiting
adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
- Penile Injection Anxiety
ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
- Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00101153 - Recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00005962 - Completed
Myeloid Leukemia
- Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
Myocardial Infarction
- Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
ClinicalTrials.gov Identifier: NCT00250068 - Recruiting
Lung Diseases; Cancer
- Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002471 - Active, not recruiting
Lymphoma; Leukemia
- A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
- T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
ClinicalTrials.gov Identifier: NCT00089180 - Recruiting
recurrent skin cancer; basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis
- Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
ClinicalTrials.gov Identifier: NCT00093444 - Active, not recruiting
Liver Cancer; Metastatic Cancer
- MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00326456 - Active, not recruiting
Ovarian Cancer
- Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00268229 - Recruiting
Leukemia
- Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
ClinicalTrials.gov Identifier: NCT00189410 - Active, not recruiting
Cancer of the Ovary Treated as 2nd Line Therapy; Muellerian Mixed Tumours; Tumours of the Uterus; Cervical Cancers; Non-Epithelial Ovarian Tumours
- Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
ClinicalTrials.gov Identifier: NCT00250016 - Recruiting
Corpus Uteri; Endometrial Cancer
- Induction Therapy Using Cytarabine, Daunorubicin, and, Optionally, Gemtuzumab Ozogamicin Followed By Consolidation Therapy With High-Dose Cytarabine and Postconsolidation Therapy With Gemtuzumab Ozogamicin Compared With No Additional Therapy in Patients W
ClinicalTrials.gov Identifier: NCT00085709 - Recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
ClinicalTrials.gov Identifier: NCT00249990 - Recruiting
Corpus Uteri; Endometrial Cancer
- Phase 2 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive ALL
ClinicalTrials.gov Identifier: NCT00130195 - Active, not recruiting
Acute Lymphoblastic Leukemia
- Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
ClinicalTrials.gov Identifier: NCT00418951 - Recruiting
Acute Myelogenous Leukemia; Myelodysplastic Syndrome
- Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00018954 - Active, not recruiting
Lymphoma; Leukemia
- Multi-National, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
ClinicalTrials.gov Identifier: NCT00538603 - Active, not recruiting
Epithelial Ovarian Cancer
- Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis
ClinicalTrials.gov Identifier: NCT00391014 - Recruiting
Acute Myeloid Leukemia; Allogeneic Haematopoietic Progenitor Cell Transplant
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00255801 - Recruiting
Lymphoma
- A Comparison of Amethocaine Cream vs. Liposomal Lidocaine Cream for Venipuncture in Children.
ClinicalTrials.gov Identifier: NCT00353002 - Recruiting
Pain
- Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00244985 - Recruiting
Lymphoma
- A Safety and Effectiveness Study of Aroplatin in Patients with Advanced Colorectal Cancer Resistant to Standard Therapies
ClinicalTrials.gov Identifier: NCT00043199 - Active, not recruiting
Colorectal Neoplasms
- Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
Myelodysplastic Syndromes
- A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.
ClinicalTrials.gov Identifier: NCT00002093 - Completed
Sarcoma, Kaposi; HIV Infections
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002665 - Active, not recruiting
Thrombocytopenia; Leukemia, Lymphocytic; Neutropenia
- Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00524810 - Active, not recruiting
Metastatic Breast Cancer
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
recurrent adult acute lymphoblastic leukemia
- Phase 3 Randomized Study of Amonafide and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary AML
ClinicalTrials.gov Identifier: NCT00509912 - Recruiting
Secondary Acute Myeloid Leukemia
- Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-Line or Later Therapy in Patients With Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Pl
ClinicalTrials.gov Identifier: NCT00216645 - Completed
Ovarian Neoplasms
- Aroplatin and Capecitabine in Patients with Advanced Colorectal Cancer Resistant to Standard Therapies
ClinicalTrials.gov Identifier: NCT00081536 - Active, not recruiting
Colorectal Neoplasms
- Aroplatin and Gemcitabine in Patients with Advanced Pancreatic Cancer Resistant to Standard Therapies
ClinicalTrials.gov Identifier: NCT00081549 - Active, not recruiting
Pancreatic Neoplasms
- Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002499 - Active, not recruiting
recurrent childhood acute lymphocytic leukemia
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005596 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia
- Pharmacokinetic Study of Liposomal Vincristine in Patients with Malignant Melanoma & Hepatic Dysfunction
ClinicalTrials.gov Identifier: NCT00145041 - Completed
Malignant Melanoma
- Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
- Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00346229 - Recruiting
Breast Cancer
- A Randomized Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging
ClinicalTrials.gov Identifier: NCT00531973 - Recruiting
Breast Cancer
- Adverse Drug Reactions of Different Brands of Ceftazidime Injection
ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
Infection
- Long-Circulating Liposomal Prednisolone Versus Pulse Intramuscular Methylprednisolone in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00241982 - Recruiting
Rheumatoid Arthritis
- Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML
ClinicalTrials.gov Identifier: NCT00430443 - Recruiting
Acute Lymphocytic Leukemia; Acute Myelogenous Leukemia
- Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00524459 - Recruiting
Breast Cancer
- Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
ClinicalTrials.gov Identifier: NCT00296010 - Recruiting
Breast Cancer
- A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00516191 - Recruiting
Multiple Myeloma
- Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00426127 - Recruiting
Pancreatic Cancer
- Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer
ClinicalTrials.gov Identifier: NCT00465673 - Recruiting
Breast Cancer
- Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
Pain
- Liposomal Doxorubicin and Docetaxel in Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00377559 - Recruiting
Breast Cancer; Neoplasm Metastasis
- Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00290732 - Recruiting
Breast Cancer
- Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00311610 - Recruiting
Colorectal Cancer
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-Azar
ClinicalTrials.gov Identifier: NCT00371995 - Not yet recruiting
Visceral Leishmaniasis
- Intermittent Liposomal Amphotericin B Primary Prophylaxis
ClinicalTrials.gov Identifier: NCT00451711 - Not yet recruiting
Acute Myeloid Leukemia
- Liposomal Doxorubicin, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00377780 - Recruiting
Breast Cancer; Neoplasm Metastasis
- Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00027989 - Active, not recruiting
stage IV breast cancer
- Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00022594 - Active, not recruiting
Neck Cancer; Oral Cancer; Throat Cancer
- Validation of Self-Reported Needle Sharing Among Injection Drug Users
ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
Viral Infection
- EPC by Intracoronary Injection in Patients With Chronic Stable Angina
ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
Coronary Artery Disease
- Liposomal Doxorubicin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004014 - Active, not recruiting
Quality of Life; recurrent prostate cancer
- Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
ClinicalTrials.gov Identifier: NCT00030784 - Active, not recruiting
adult soft tissue sarcoma
- A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003671 - Active, not recruiting
B-cell childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
- Combination Chemotherapy in Treating Children With Lymphoma
ClinicalTrials.gov Identifier: NCT00002590 - Active, not recruiting
stage IV childhood large cell lymphoma; stage IV childhood lymphoblastic lymphoma
- Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women with Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00005980 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00544999 - Not yet recruiting
Leukemia
- A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00002318 - Active, not recruiting
Sarcoma, Kaposi; HIV Infections
- T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
ClinicalTrials.gov Identifier: NCT00002811 - Active, not recruiting
actinic keratosis; prevention of skin cancer
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00016302 - Active, not recruiting
untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005603 - Active, not recruiting
childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00005585 - Active, not recruiting
childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
- The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
- Study of Functional Microarray-Facilitated Lidocaine Liposomal Cream Absorption for Cutaneous Anesthesia in Volunteers
ClinicalTrials.gov Identifier: NCT00387296 - Not yet recruiting
Wounds
- Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
Type A Botulinum Toxin; Tennis Elbow
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
